UMediC Group Berhad
UMediC Group Berhad, an investment holding company, develops, manufactures, markets, and distributes medical devices and consumables in Malaysia, the Asia Pacific, the Americas, Europe, the Middle East, Africa, and Oceania. The company operates nursing homes and healthcare centers, and other related services; markets and distributes laboratory equipment and consumables; and provides after-sales s… Read more
UMediC Group Berhad (0256) - Total Liabilities
Latest total liabilities as of October 2025: RM11.72 Million MYR
Based on the latest financial reports, UMediC Group Berhad (0256) has total liabilities worth RM11.72 Million MYR as of October 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
UMediC Group Berhad - Total Liabilities Trend (2020–2025)
This chart illustrates how UMediC Group Berhad's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
UMediC Group Berhad Competitors by Total Liabilities
The table below lists competitors of UMediC Group Berhad ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Electro-Sensors Inc
NASDAQ:ELSE
|
USA | $1.05 Million |
|
Indomobil Multi Jasa Tbk
JK:IMJS
|
Indonesia | Rp26.66 Trillion |
|
Curative Biotechnology Inc
NYSE MKT:CUBT
|
USA | $7.28 Million |
|
Pool Advista Indonesia Tbk
JK:POOL
|
Indonesia | Rp11.50 Billion |
|
ADVFN Plc
PINK:AVFCF
|
USA | $1.35 Million |
|
NeuroMetrix Inc
NASDAQ:NURO
|
USA | $1.01 Million |
|
Thai Nam Plastic Public Company Limited
BK:TNPC
|
Thailand | ฿773.48 Million |
Liability Composition Analysis (2020–2025)
This chart breaks down UMediC Group Berhad's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 7.22 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how UMediC Group Berhad's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for UMediC Group Berhad (2020–2025)
The table below shows the annual total liabilities of UMediC Group Berhad from 2020 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-07-31 | RM9.87 Million | -0.70% |
| 2024-07-31 | RM9.93 Million | +1.21% |
| 2023-07-31 | RM9.82 Million | -39.46% |
| 2022-07-31 | RM16.21 Million | -52.58% |
| 2021-07-31 | RM34.19 Million | +47.06% |
| 2020-07-31 | RM23.25 Million | -- |